SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,635,505 | +229.3% | 150,599 | +468.3% | 0.00% | +300.0% |
| Q1 2024 | $496,610 | -9.8% | 26,500 | +4.3% | 0.00% | 0.0% |
| Q4 2023 | $550,418 | -73.5% | 25,400 | -42.4% | 0.00% | -80.0% |
| Q2 2023 | $2,073,488 | -62.5% | 44,098 | -66.5% | 0.01% | -64.3% |
| Q1 2023 | $5,530,244 | -7.2% | 131,798 | -15.7% | 0.01% | -17.6% |
| Q4 2022 | $5,961,206 | +12.5% | 156,298 | +15.5% | 0.02% | +13.3% |
| Q3 2022 | $5,298,000 | +142.7% | 135,298 | +100.2% | 0.02% | +150.0% |
| Q2 2022 | $2,183,000 | +60.9% | 67,598 | +64.9% | 0.01% | +50.0% |
| Q1 2022 | $1,357,000 | -29.4% | 41,000 | -9.3% | 0.00% | -20.0% |
| Q4 2021 | $1,923,000 | -10.5% | 45,200 | -6.8% | 0.01% | -16.7% |
| Q3 2021 | $2,149,000 | -83.4% | 48,500 | -78.7% | 0.01% | -82.4% |
| Q2 2021 | $12,941,000 | -52.3% | 227,799 | -37.2% | 0.03% | -54.7% |
| Q1 2021 | $27,148,000 | -25.6% | 362,699 | -14.0% | 0.08% | -22.7% |
| Q4 2020 | $36,490,000 | +12.3% | 421,799 | -20.6% | 0.10% | +4.3% |
| Q3 2020 | $32,479,000 | +6.7% | 531,399 | -27.4% | 0.09% | +4.5% |
| Q2 2020 | $30,437,000 | +135.4% | 731,999 | +62.6% | 0.09% | +81.6% |
| Q1 2020 | $12,930,000 | +1435.6% | 450,199 | +7403.3% | 0.05% | +2350.0% |
| Q3 2019 | $842,000 | -57.3% | 6,000 | -52.4% | 0.00% | -60.0% |
| Q2 2018 | $1,972,000 | -63.8% | 12,600 | -62.7% | 0.01% | -66.7% |
| Q1 2018 | $5,444,000 | +156.2% | 33,800 | +162.0% | 0.02% | +150.0% |
| Q4 2017 | $2,125,000 | +852.9% | 12,900 | +360.7% | 0.01% | +500.0% |
| Q2 2017 | $223,000 | -23.4% | 2,800 | -31.7% | 0.00% | 0.0% |
| Q1 2017 | $291,000 | – | 4,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 99,306 | $14,027,000 | 5.76% |
| Casdin Capital, LLC | 312,000 | $44,070,000 | 5.36% |
| Palo Alto Investors LP | 840,372 | $118,703,000 | 4.80% |
| BB BIOTECH AG | 1,071,373 | $151,331,000 | 4.00% |
| TRV GP II, LLC | 37,362 | $5,277,000 | 3.10% |
| Eversept Partners, LP | 43,621 | $6,161,466 | 2.70% |
| RA Capital Management | 350,933 | $49,569,000 | 2.65% |
| Eventide Asset Management | 494,000 | $69,778,000 | 2.56% |
| OAK RIDGE INVESTMENTS LLC | 241,099 | $34,055,000 | 1.88% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 93,000 | $13,136,000 | 1.87% |